Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

45.57
Delayed Data
As of May 02
 -0.09 / -0.20%
Today’s Change
30.93
Today|||52-Week Range
49.25
+19.42%
Year-to-Date

Today’s Trading

Previous close45.66
Today’s open45.68
Day’s range44.85 - 46.68
Volume208,573
Average volume (3 months)172,950
Market cap$674.3M
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)-19.92%
Earnings growth (this year)-17.54%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-11.93%
P/E ratio22.7
Price/Sales6.29
Price/Book3.26

Competitors

 Today’s
change
Today’s
% change
KTWOK2M Group Holdings I...-0.39-2.40%
EXASExact Sciences Corp-0.03-0.43%
ATRIAtrion Corp+0.74+0.19%
CERSCerus Corp-0.02-0.32%
Data as of 3:59pm ET, 05/02/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.42
Annual revenue (last year)$93.0M
Annual profit (last year)$30.8M
Net profit margin33.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Dana M. Alexander
Corporate headquarters
Bedford, Massachusetts

Forecasts

Partner Offers

Search for Jobs